Autolus Therapeutics Ltd
Biotechnology
Healthcare
AUTL
266 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.37
52 week high
4.80
high
1.40
52 week low
0.00
previous Close
1.38
P/E ratio
market cap
625 M
div yield
0
net profit margin
0.00 %
781.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top